Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells
Sandra Tobón‐Cornejo, Ariana Vargas‐Castillo, Mandy Juárez, Joshua Ayork Acevedo-Carabantes, Lilia Guadalupe Noriega, Omar Granados‐Portillo, Alma Delia Chávez-Blanco, Rocío Morales‐Bárcenas, Nimbe Torres, Armando Roberto Tovar, Alejandro Schcolnik‐Cabrera
This study shows that low-dose genistein combined with chemotherapy reduces breast cancer cell viability and migration by altering metabolic pathways, particularly fatty acid metabolism.
Life Sciences · Mar 14, 2025Peer-reviewedCancer Biology